U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501039) titled 'A Phase 1 Study of BLKR201 in Healthy Adult Participants' on March 19.
Brief Summary: The goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR201 and how food may affect it.
The main questions this study aims to answer are:
* Is BLKR201 safe and well tolerated when taken as a single dose or for several days in a row?
* How does BLKR201 move through and leave the body?
* Does taking BLKR201 with food change how the body absorbs it?
Researchers will compare BLKR201 to a placebo (a look-alike tablet that contains no drug) in most parts of...